Two phase I studies of low dose recombinant human IL-12 with Melan-A and influenza peptides in subjects with advanced malignant melanoma
Cebon, Jonathan, Jäger, Elke, Shackleton, Mark J, Gibbs, Peter, Davis, Ian D, Hopkins, Wendie, Gibbs, Sharen, Chen, Qiyuan, Karbach, Julia, Jackson, Heather, MacGregor, Duncan P, Sturrock, Sue, Vaughan, Hilary, Maraskovsky, Eugene, Neumann, Antje, Hoffman, Eric, Sherman, Mathew L, Knuth, Alexander
Published in Cancer immunity (16.07.2003)
Get full text
Published in Cancer immunity (16.07.2003)
Journal Article